参考文献
1.Goéré, DianeDucreux, M et al. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 study.The Lancet Oncology, doi:https://doi.org/10.1016/S1470-2045(20)30322-3
2. James A E et al. Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer. J Clin Oncol. 2020 Jul 24;JCO2000315. doi: 10.1200/JCO.20.00315. Online ahead of print.3. Eric Van Cutsem et al. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma. J Clin Oncol. 2020 Jul 24;JCO2000590. doi: 10.1200/JCO.20.00590. Online ahead of print.4. Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study doi:10.1038/s41408-020-00342-x5. https://mp.weixin.qq.com/s/_OWozYYF4WqtUysGHM4Qng6. Pan H, Zhang K, Wang M, Ling L, Wang S, Zhou W. The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population-based observational study. Cancer. 2020;126 Suppl 16:3830-3836. doi:10.1002/cncr.32829。7. https://mp.weixin.qq.com/s/dHcOADGVxpN2lBpNdfqyKg8.https://www.prnewswire.com/news-releases/bd-receives-fda-approval-for-hpv-test-with-extended-genotyping-capabilities-301097526.html